Showing results (301-310 of 831) with videos related to

Sort By:
Pageof 84
Vaccine|January 19, 2021
The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL)Jennifer A Whitaker, Sameer A Parikh, Tait D Shanafelt, et al.
Cancer|August 8, 2013
Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic leukemia (CLL)Tait Shanafelt, Mark C Lanasa, Timothy G Call, et al.
Blood|November 19, 2008
B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcomeTait D Shanafelt, Neil E Kay, Greg Jenkins, et al.
Thrombosis and Haemostasis|August 17, 2018
Analytical Considerations in Nanoscale Flow Cytometry of Extracellular Vesicles to Achieve Data LinearityJanice Gomes, Fabrice Lucien, Tyler T Cooper, et al.
Cancer|July 13, 2006
Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemiaStefan Faderl, Kanti Rai, John Gribben, et al.
Cancer|January 11, 2011
Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemiaGloria N Mattiuzzi, Jorge E Cortes, Deborah A Blamble, et al.
Blood|July 13, 2007
Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phaseElias Jabbour, Hagop M Kantarjian, Lynne V Abruzzo, et al.
Cancer|August 26, 2010
Defining the course and prognosis of adults with acute lymphocytic leukemia in first salvage after induction failure or short first remission durationHagop M Kantarjian, Deborah Thomas, Farhad Ravandi, et al.
Cancer|September 17, 2010
Current event-free survival after sequential tyrosine kinase inhibitor therapy for chronic myeloid leukemiaAref Al-Kali, Hagop Kantarjian, Jianqin Shan, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 25, 2013
Retrospective analysis of prognostic factors associated with response and overall survival by baseline marrow blast percentage in patients with myelodysplastic syndromes treated with decitabineElias Jabbour, Hagop Kantarjian, Susan O'Brien, et al.
Pageof 84